Greeting

It is an honour and a privilege to invite you to Mannheim to attend the 1st International Sonothrombolysis Conference. This conference will cover all aspects of an exciting new therapeutic strategy for treating vascular disease and thus be of keen interest to both researchers and clinicians alike.

Indeed, this first meeting will likely set the stage for one of the most important new conferences in the fields of cardiovascular and cerebrovascular diseases.
The program includes state-of-the-art lectures by esteemed international authorities in the fields of ultrasound therapy, drug delivery, and nanotechnology as well as presentations of new results from leading research institutions. We hope that this first conference will bring new solutions and hopes for the treatment
of patients with vascular disease.

Stephen Meairs
Conference Chairman